Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

 5.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 22.25p
  • 52 Week Low: 3.13p
  • Currency: UK Pounds
  • Shares Issued: 143.14m
  • Volume: 0
  • Market Cap: £7.16m
  • RiskGrade: 747

Genedrive finance chief announces April departure

By Josh White

Date: Wednesday 02 Mar 2022

LONDON (ShareCast) - (Sharecast News) - Molecular diagnostics company Genedrive said on Wednesday that its chief financial officer Matthew Fowler would be leaving it and stepping down from the board on 19 April.

The AIM-traded firm had announced on 16 November that Fowler intended to stand down after five years in the role.

His departure was being made so he could take up the CFO position at second-hand and refurbished products retailer musicMagpie.

"The company will make a further announcement in due course with regards to recruitment of a new chief financial officer," the Genedrive board said in its statement.

At 1434 GMT, shares in Genedrive were down 6.6% at 13.31p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 5.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 22.25p
52 Week Low 3.13p
Volume 0
Shares Issued 143.14m
Market Cap £7.16m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.55% below the market average40.55% below the market average40.55% below the market average40.55% below the market average40.55% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average
Price Trend
91.03% below the market average91.03% below the market average91.03% below the market average91.03% below the market average91.03% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average
Income Not Available
Growth
44.6% below the market average44.6% below the market average44.6% below the market average44.6% below the market average44.6% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Genedrive Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Genedrive Key Personnel

CFO Russell Shaw
CEO James Cheek

Top of Page